✦ LIBER ✦

Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer

✍ Scribed by Dr Martin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, Ingo Diel, Bengt Bergström

Book ID: 119930096
Publisher: Springer International Publishing AG
Year: 2006
Tongue: English
Weight: 110 KB
Volume: 26
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200626060-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term (4-year) safety of intravenous

Long-term (4-year) safety of intravenous Ibandronate in metastatic breast cancer: an open-label study

✍ M Pecherstorfer; I.J Diel; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB

461 PUBLICATION Long-term safety of intr

461 PUBLICATION Long-term safety of intravenous ibandronate throughout 4 years of treatment for metastatic breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

444 PUBLICATION Long-term safety of oral

444 PUBLICATION Long-term safety of oral ibandronate for metastatic breast cancer: 4-year treatment data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Renal Safety of Intravenous Ibandronic A

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

✍ Dr Nina V. Lyubimova, Nikolay E. Kushlinsky, Michail R. Lichinitser, Karl Schlos 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Long-term safety of oral ibandronate in

Long-term safety of oral ibandronate in patients with skeletal metastases from breast cancer: 4-year follow-up data

✍ D Cameron; R Murray; D Tripathy; B Bergström 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

408 POSTER Safety comparison of oral iba

408 POSTER Safety comparison of oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Phase III data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB